Ann: Anteo Makes Solid Progress With Geneodx Partnership, page-41

just working thru anteo's ann over the last year and come up with one of brick's cryptic, 6th degrees of separation.

form 21/2/2019 ann, saying we have signed a distribution agreement. main point sinopharm

Anteo said it had signed a distribution agreement with Chinese company Shanghai GeneoDx Biotechnology, a diagnostic product and distribution company, currently affiliated to China National Pharmaceutical Group (SINOPHARM), a Chinese state-owned enterprise with annual revenues of around CNY247 billion (A$49 billion) and total assets of almost CNY200 billion (A$40 billion).
GeneoDx will have the exclusive right to market, sell and distribute Anteo’s range of AnteoBind products in China, specifically within the Chinese In-Vitro Diagnostics (IVD) market and targeting “market-leading Chinese manufacturers of Point of Care (PoC) and diagnostics products”

from Charlie Huang linkedin page (head of research at anteo technologies) in the interests section, he has Guangchang Guo as an influencer (I know it doesn't mean anything, just somebody he admires) ranked in 2015 as the 34th richest person in china.

then we have Guangchang being previous the chairman of Sinopharm and now chairman of Fosun intl ltd.
hey I know its not as cryptic as brick's and very vague but I found it interesting. be nice to get an update of our china inroads, especially since the recent job advertised for a customer support specialist said additional languages such as Mandarin Chinese will be highly regarded. and must hold a valid work permit visa.